Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
about
A review of UHMWPE wear-induced osteolysis: the role for early detection of the immune response.Cell tracking technologies for acute ischemic brain injuryRecognition of Immune Response for the Early Diagnosis and Treatment of Osteoarthritis.Targeting formyl peptide receptor 1 of activated macrophages to monitor inflammation of experimental osteoarthritis in rat.Imaging Neuroinflammation - from Bench to Bedside.Critical design issues in the targeted molecular imaging of cell surface receptors.A gadolinium(iii) complex based dual-modal probe for MRI and fluorescence sensing of fluoride ions in aqueous medium and in vivo.PET imaging of inflammation biomarkers.The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.Final step gallium-68 radiolabelling of silica-coated iron oxide nanorods as potential PET/MR multimodal imaging agents.(99m)Tc SPECT imaging agent based on cFLFLFK for the detection of FPR1 in inflammation.
P2860
Q26741081-97066A39-6F79-4DB9-B8C7-351B074A8B2DQ28084529-617803B0-E043-46FA-9370-46F29E3E6E22Q28085009-BBCFEA4B-A34C-4F75-A3BA-3A653CEA3399Q30277841-F74E131A-0EAC-4132-9750-A05CF0E4898DQ30881154-408C236C-C159-4826-A14F-7FD371DCBD79Q30899036-D5262CFA-9329-4A1C-B5DE-7430E9588DE2Q31141434-98C42EE9-2218-46F7-9BFB-27B8C29875CAQ36997603-ED0C39E6-84DD-4032-B682-B07F3D83A894Q38080002-2BCFB5D1-08F8-472D-B97F-82B9F761416AQ39111564-17483435-9112-4177-8F53-2B0B412A349BQ41532744-3C452D40-ABA9-408D-8D1F-6207431747CC
P2860
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@en
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@nl
type
label
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@en
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@nl
prefLabel
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@en
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@nl
P2093
P2860
P356
P1476
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.
@en
P2093
Felicity N E Gavins
Helen Smith
Jordi L Tremoleda
Marzena Wylezinska-Arridge
Nicholas J Long
Sajinder Kaur Luthra
Veronique Morisson Iveson
P2860
P304
P356
10.1039/C2CC37460A
P407
P577
2012-12-04T00:00:00Z